Hillevax (HLVX) Stock Price

Hillevax Price

NASDAQ·CLOSED
2.09
​
Market closed

The consensus 12-month price target for Hillevax is 2.04 USD, about 2.4% below where the stock trades today. Of 7 analysts, 0 rate the stock a buy — an overall Sell consensus.

Hillevax stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hillevax business model & stock analysis

HilleVax, Inc. develops and commercializes novel vaccines, focusing on HIL-214, a bivalent virus-like particle (VLP) vaccine candidate for norovirus-induced acute gastroenteritis. The vaccine combines VLPs for norovirus genotypes GI.1 and GII.4 with an aluminum hydroxide adjuvant to enhance immune response. HIL-214 targets moderate-to-severe cases of norovirus infection, which causes symptoms like diarrhea, vomiting, and dehydration. The company's primary revenue stream will come from the future commercialization of HIL-214 after regulatory approval, with potential sales to healthcare providers and public health programs.

Frequently asked questions about Hillevax

Analysts currently set an average price target of 2.04 USD for the Hillevax stock (median: 2.04 USD), implying -2.4 % versus the latest price. The consensus is based on 7 analyst ratings.

7 analysts currently rate the Hillevax stock: 0 recommend buying, 4 holding and 3 selling.

Converted at the current exchange rate, the Hillevax share trades at 1.90 EUR (2.09 USD).

The Hillevax share (HLVX) is listed on 1 stock exchanges, including: NASDAQ (HLVX).

The revenue cannot currently be calculated for Hillevax.

The expected profit of Hillevax is -23.06 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Hillevax is currently -4.49. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Hillevax stock.

The P/S cannot be calculated for Hillevax currently.

The Eulerpool Quality Score for Hillevax is 3/10.

The ISIN of Hillevax is US43157M1027. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Hillevax is HLVX. The ticker symbol is used to trade Hillevax shares on the stock exchange.

Fair ValueTerminal
1.86 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website hillevax.com
Currency
USD
Initial public offering
Apr 29, 2022
ISIN
US43157M1027
Cusip
43157M102
Market capitalization
104.79 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2025
-4.22
P/Ee 2026
-4.49
P/Ee 2027
-4.81
P/Ee 2028
-10.88
P/Ee 2029
104.50
P/S
P/Se
—
EV/EBIT
0.32
P/B Ratio
0.68
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-95.33 %
Last updated Nov 20, 2026, 2:06 AM

Hillevax Peer Group

Hillevax Ticker

NASDAQ · HLVX

Hillevax FIGI

HLVX:US · BBG012FCPWH5HLVX:UA · BBG016M9WR97HLVX:UC · BBG016M9WRB4HLVX:UN · BBG016M9WRD2HLVX:UP · BBG016M9WRF0HLVX:UB · BBG016M9WRH8HLVX:UM · BBG016M9WRK4HLVX:UX · BBG016M9WRL3HLVX:UD · BBG016M9WRR7HLVX:UW · BBG016M9WRT5HLVX:UF · BBG016M9WRV2HLVX:VY · BBG016M9WRW1

All fundamentals and in-depth analysis of Hillevax

Our stock analysis for Hillevax stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hillevax. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.